Aktionsplan Livzon Pharmaceutical Group Inc.
Über das Unternehmen Livzon Pharmaceutical Group Inc.
Livzon Pharmaceutical Group Inc. занимается исследованиями, разработками, производством и продажей фармацевтических продуктов, а также активных фармацевтических ингредиентов и промежуточных продуктов в Китайской Народной Республике. weitere details| ISIN | CNE100001QV5 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Див.доход ао | 13.61 |
| Дивиденд ао | 1.48 |
| Сайт | https://www.livzon.com.cn |
| Цена ао | 26.75 |
| Preisänderung pro Tag: | 0% (26.75) |
|---|---|
| Preisänderung pro Woche: | +2.49% (26.1) |
| Preisänderung pro Monat: | -0.1866% (26.8) |
| Preisänderung über 3 Monate: | -0.3724% (26.85) |
| Preisänderung über sechs Monate: | +5.11% (25.45) |
| Preisänderung pro Jahr: | -3.43% (27.7) |
| Preisänderung über 3 Jahre: | +8.96% (24.55) |
| Preisänderung über 5 Jahre: | -9.32% (29.5) |
| Preisänderung seit Jahresbeginn: | -0.3724% (26.85) |
|
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
|||||||||||||||||||||||||||||||||||||
| Institutionen | Volumen | Aktie, % |
|---|---|---|
| Vanguard International Stock Index-Emerging Markets Stk | 1796853 | 0.58 |
| Vanguard International Stock Index-Total Intl Stock Indx | 1747705 | 0.56 |
| DFA Emerging Markets Core Equity Portfolio | 1187017 | 0.38 |
| DFA Emerging Markets Small Cap Series | 641903 | 0.21 |
| SPDR Portfolio Emerging Markets ETF | 415727 | 0.13 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S. Index Fund | 344871 | 0.11 |
| WisdomTree Tr-Wisdom Tree Emerging Markets High Dividend Fd | 276500 | 0.09 |
| DFA Investment Dimensions-DFA Emerging Mkts Value | 234700 | 0.08 |
| Schwab Strategic Tr-Schwab Emerging Markets Equity ETF | 176365 | 0.06 |
| Dimensional ETF Tr-Dimensional World ex U.S. Core Equity 2 ETF | 141156 | 0.05 |
| ETF | Aktie, % | Rentabilität für das Jahr, % | Dividenden, % |
|---|---|---|---|
| Loncar China BioPharma ETF | 1.93 | 18434.25 | |
| Dimensional Emerging Markets High Profitability ETF | 0.1979 | 13.33 | 3.65615 |
| SPDR S&P Emerging Markets Small Cap ETF | 0.19314 | 5.46 | 3.03583 |
| WisdomTree Emerging Markets SmallCap Dividend Fund | 0.17685 | 1.35 | 5.00999 |
| iShares MSCI Emerging Markets Small-Cap ETF | 0.17081 | 7.67 | 2.7853 |
| Avantis Emerging Markets Value ETF | 0.1365 | 14.12 | 4.22231 |
| Avantis Emerging Markets Equity ETF | 0.08291 | 8.77 | 3.60513 |
| Dimensional Emerging Markets Core Equity 2 ETF | 0.07294 | 15.96 | 3.34087 |
Vanguard FTSE All-World ex-US Small-Cap ETF
|
0.07 | 9.39 | 3.09932 |
| Dimensional Emerging Markets Value ETF | 0.02299 | 17.07 | 4.19508 |
| Dimensional World ex U.S. Core Equity 2 ETF | 0.02069 | 13.06 | 3.62488 |
FINEX CHINA UCITS ETF
|
0.02 | -34.73 | |
| FlexShares Morningstar Emerging Markets Factor Tilt Index Fund | 0.01489 | 12.46 | 3.59676 |
iShares Core MSCI Total International Stock ETF
|
0.00931 | 6.4 | 3.25258 |
| SPDR Portfolio Emerging Markets ETF | 0.00867 | 11.59 | 3.1879 |
| 0.21 | 1 235.74 | 3.11 |
| Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
|---|---|---|---|
| Mr. Yanggang Tang | President & Executive Director | N/A | 1970 (55 Jahre) |
| Mr. Guoxiang Xu | Executive Vice Chairman & VP of Sales | N/A | 1963 (62 Jahr) |
| Ms. Yanxia Si | VP & CFO | N/A | 1968 (57 Jahre) |
| Mr. Liang Yang | VP, Secretary to the Board & Company Secretary | N/A | 1983 (42 Jahr) |
| Mr. Daihong Yang | Vice President | N/A | 1967 (58 Jahre) |
| Ms. Yuxuan Huang | Vice President | N/A | 1968 (57 Jahre) |
| Jianing Liu | Chief Investment Officer & Head of BD Dept. | N/A | |
| Ms. Jianying Zhuang | Head of Accounting Department | N/A | |
| Mr. Jun Du | Vice President | 1977 (48 Jahre) | |
| Mr. Maolin Wang | Chief Supervisor and GM of Legal & Compliance | 1966 (59 Jahre) |
Adresse: China, Zhuhai, Headquarters Building - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.livzon.com.cn
Webseite: https://www.livzon.com.cn
